<< Read Full Article
<< Read Full Article
Thursday's Analysts' Upgrades and Downgrades
CHANGE IN RATINGS
Abbott Laboratories (ABT Quote) downgraded at Wachovia to Market Perform. Estimates also cut, as the company is facing several challenges at its key franchises.Broadcom(BRCM Quote) initiated at UBS with Buy rating. Price target starts at $47 and FY 2008 EPS estimates set at $0.47.
BRE Properties (BRE Quote) upgraded at Credit Suisse to Outperform from Neutral. Cites high portfolio quality at discounted valuation. Raised target price to $65 from $50.
Celestica (CLS Quote) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call, as the stock is trading near tangible book value. Downside appears limited from current levels. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet